Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance
- PMID: 32488850
- PMCID: PMC7363737
- DOI: 10.1007/s13402-020-00519-3
Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance
Abstract
Background: Tumor initiation and subsequent progression are usually long-term processes, spread over time and conditioned by diverse aspects. Many cancers develop on the basis of chronic inflammation; however, despite dozens of years of research, little is known about the factors triggering neoplastic transformation under these conditions. Molecular characterization of both pathogenetic states, i.e., similarities and differences between chronic inflammation and cancer, is also poorly defined. The secretory activity of tumor cells may change the immunophenotype of immune cells and modify the extracellular microenvironment, which allows the bypass of host defense mechanisms and seems to have diagnostic and prognostic value. The phenomenon of immunosuppression is also present during chronic inflammation, and the development of cancer, due to its duration, predisposes patients to the promotion of chronic inflammation. The aim of our work was to discuss the above issues based on the latest scientific insights. A theoretical mechanism of cancer immunosuppression is also proposed.
Conclusions: Development of solid tumors may occur both during acute and chronic phases of inflammation. Differences in the regulation of immune responses between precancerous states and the cancers resulting from them emphasize the importance of immunosuppressive factors in oncogenesis. Cancer cells may, through their secretory activity and extracellular transport mechanisms, enhance deterioration of the immune system which, in turn, may have prognostic implications.
Keywords: Cancer; immune response; immune system; immunosuppression; inflammation; solid tumor.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
The multi-faceted roles of prostaglandin E2 in cancer-infiltrating mononuclear phagocyte biology.Immunobiology. 2012 Dec;217(12):1225-32. doi: 10.1016/j.imbio.2012.05.001. Epub 2012 May 11. Immunobiology. 2012. PMID: 22727331 Review.
-
The fundamental role of mechanical properties in the progression of cancer disease and inflammation.Rep Prog Phys. 2014 Jul;77(7):076602. doi: 10.1088/0034-4885/77/7/076602. Epub 2014 Jul 9. Rep Prog Phys. 2014. PMID: 25006689 Review.
-
Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells.Expert Rev Clin Immunol. 2015;11(7):849-57. doi: 10.1586/1744666X.2015.1043893. Epub 2015 May 8. Expert Rev Clin Immunol. 2015. PMID: 25954917 Free PMC article. Review.
-
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011. Cancer Immunol Res. 2016. PMID: 27036971 Free PMC article. Review.
-
Balancing the innate immune system in tumor development.Trends Cell Biol. 2015 Apr;25(4):214-20. doi: 10.1016/j.tcb.2014.11.001. Epub 2014 Nov 28. Trends Cell Biol. 2015. PMID: 25444276 Free PMC article. Review.
Cited by
-
Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta-analysis, and meta-regression.Cancer Med. 2021 Mar;10(5):1690-1714. doi: 10.1002/cam4.3773. Epub 2021 Feb 16. Cancer Med. 2021. PMID: 33591628 Free PMC article.
-
Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma.Cancer Immunol Immunother. 2022 Aug;71(8):1937-1947. doi: 10.1007/s00262-021-03127-8. Epub 2021 Dec 20. Cancer Immunol Immunother. 2022. PMID: 34928423 Free PMC article.
-
Paving the Path for Immune Enhancing Nutrition in Colon Cancer: Modulation of Tumor Microenvironment and Optimization of Outcomes and Costs.Cancers (Basel). 2023 Jan 10;15(2):437. doi: 10.3390/cancers15020437. Cancers (Basel). 2023. PMID: 36672387 Free PMC article.
-
New insights into the role of the CHI3L2 protein in invasive ductal breast carcinoma.Sci Rep. 2024 Nov 18;14(1):28529. doi: 10.1038/s41598-024-77930-5. Sci Rep. 2024. PMID: 39557919 Free PMC article.
-
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.Front Immunol. 2021 Jun 17;12:683381. doi: 10.3389/fimmu.2021.683381. eCollection 2021. Front Immunol. 2021. PMID: 34220833 Free PMC article. Review.
References
-
- K. T. Schultz, F. Grieder, Structure and function of the immune system. Toxicol. Pathol. 15, 262–264 (1987) - PubMed
-
- L. V. Parijs, Homeostasis and self-tolerance in the immune ssystem: Turning lymphocytes off. Science 280, 243–248 (1998) - PubMed
-
- M. Bradshaw, J. Linnoila, An overview of autoimmune and paraneoplastic encephalitides. Semin. Neurol. 38, 330–343 (2018) - PubMed
-
- J. Wu, X. Xu, E. J. Lee, A. Y. Shull, L. Pei, F. Awan, X. Wang, J. H. Choi, L. Deng, H. B. Xin, W. Zhong, J. Liang, Y. Miao, Y. Wu, L. Fan, J. Li, W. Xu, H. Shi, Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming. Oncotarget 7, 40558–40570 (2016) - PMC - PubMed
-
- V. Friman, O. Winqvist, C. Blimark, P. Langerbeins, H. Chapel, F. Dhalla, Secondary immunodeficiency in lymphoproliferative malignancies. Hematol. Oncol. 34, 121–132 (2016) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources